SCIENTIFIC POGRAMME 16 th EADO CONGRESS 4 FINAL PROGRAMME 22-25 APRIL, 2020, RADISSON BLU HOTEL LIETUVA, VILNIUS, LITHUANIA ALFA HALL BETA HALL ZETA HALL 09:00–12:15 DERMATOSCOPY COURSE 1 SCOPE SATELLITE SYMPOSIUM AT THE EADO 12:15–13:00 COFFEE BREAK, VISIT TO THE EXHIBITION & POSTER VIEWING 13:00–13:15 OPENING CEREMONY 13:15–14:15 KEYNOTE LECTURES 1 Skin cancer prevention Classification of melanoma 14:30–15:30 INDUSTRY SATELLITE SYMPOSIUM 1 15:30–17:00 SYMPOSIUM 1 Advanced BCC classification and treatment SYMPOSIUM 2 Biology of skin cancer 17:00–17:30 COFFEE BREAK, VISIT TO THE EXHIBITION & POSTER VIEWING 17:30–18:45 SYMPOSIUM 3 Management of nevi SYMPOSIUM 4 Barriers to access to innovative medicines and successful access schemes in Europe: multi– stakeholder panel discussion 19:00–22:30 NETWORKING EVENING Wednesday, April 22 Wednesday, Aprill 22
21
Embed
EADO CONGRESS SCIENTIFIC POGRAMME · 10:00–10:18 The beginners guide to avoid mistakes Giuseppe Argenziano (Naples, Italy) 10:20–10:38 Gray Color and its significance Iris Zalaudek
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
SCIENTIFIC POGRAMME16th EADO CONGRESS
4 F I N A L P R O G R A M M E
22-25 APRIL, 2020, RADISSON BLU HOTEL LIETUVA, VILNIUS, LITHUANIA
ALFA HALL BETA HALL ZETA HALL
09:00–12:15 DERMATOSCOPY COURSE 1 SCOPE SATELLITE SYMPOSIUM AT THE EADO
12:15–13:00 COFFEE BREAK, VISIT TO THE EXHIBITION & POSTER VIEWING
13:00–13:15 OPENING CEREMONY
13:15–14:15 KEYNOTE LECTURES 1Skin cancer preventionClassification of melanoma
14:30–15:30 INDUSTRY SATELLITE SYMPOSIUM 1
15:30–17:00 SYMPOSIUM 1Advanced BCC classification and treatment
SYMPOSIUM 2Biology of skin cancer
17:00–17:30 COFFEE BREAK, VISIT TO THE EXHIBITION & POSTER VIEWING
17:30–18:45 SYMPOSIUM 3Management of nevi
SYMPOSIUM 4Barriers to access to innovative medicines and successful access schemes in Europe: multi–stakeholder panel discussion
19:00–22:30 NETWORKING EVENING
Wednesday, April 22
Wed
nesd
ay, A
prill
22
5w w w . e a d o 2 0 2 0 . c o m
22-25 APRIL, 2020, RADISSON BLU HOTEL LIETUVA, VILNIUS, LITHUANIA
17:00–17:30 COFFEE BREAK. VISIT TO THE EXHIBITION & POSTER VIEWING
17:30–18:45 SYMPOSIUM 3MANAGEMENT OF NEVICHAIRS: Giuseppe Argenziano (Naples, Italy)
Harald Kittler (Vienna, Austria)
17:30–17:42 The comparative approach and beyond Giuseppe Argenziano (Naples, Italy)
17:45–17:57 The “dysplastic” nevus Harald Kittler (Vienna, Austria)
18:00–18:12 The “Spitz” nevus Aimilios Lallas (Thessaloniki, Greece)
18:15–18:27 Digital monitoring: best indications Elvira Moscarella (Naples, Italy)
18:30–18:42 The blue and the non–blue congenital nevus Susanna Puig (Barcelona, Spain)
19:00–22:30 NETWORKING EVENING NATIONAL GALLERY OF ARTKonstitucijos ave. 22
ALFA HALL
ALFA HALL
Wednesday, April 22
Wed
nesd
ay, A
prill
22
Dermatoscopy course Scope satellite symposium at the EADO Keynote lecturesOpening ceremony Industry satellite symposium
Closing ceremony & awards Industry satellite lunch symposiumSymposium Social meeting
7w w w . e a d o 2 0 2 0 . c o m
22-25 APRIL, 2020, RADISSON BLU HOTEL LIETUVA, VILNIUS, LITHUANIA
09:00–12:15 SCOPE SATELLITE SYMPOSIUM AT THE EADO CHAIRS: Alexandra Geusau (Vienna, Austria)
Deniz Seckin (Ankara, Turkey)
09:00–09:05 Welcome and introduction
09:05–09:25 Non–melanoma skin cancer incidence after organ transplantation Jan Nico Bouwes Bavinck (Leiden, The Netherlands)
09:28–09:48 Skin cancer following solid organ transplantation–the role of immunosuppression (including Q&A) Oscar Colegio (New York, USA)
09:51–10:11 AK therapy and skin cancer prevention in high–risk transplant recipients (including Q&A) Klara Mosterd (Maastricht, The Netherlands)
10:14–10:34 Checkpoint inhibitor therapy for cancer in solid organ transplant recipients: A systematic review (including Q&A) Celeste Lebbé (Paris, France)
10:40 –11:00 COFFEE BREAK
CHAIRS: Charlotte M. Proby (Dundee, UK)Jan Nico Bouwes Bavinck (Leiden, The Netherlands)
11:23–11:43 Skin cancer in chronic lymphocytic leukaemia Ulrike Leiter–Stöppke (Tuebingen, Germany) Andreas Meiwes (Tuebingen, Germany)
CHAIRS: Oscar Colegio (New York, USA) Carla Ferrandiz–Pulido (Barcelona, Spain)Veronique del Marmol (Brussels, Belgium)Mirjam Nägeli (Zurich, Switzerland)Elsemieke Plasmeijer (Leiden, The Netherlands)
11:45–12:20 Tumour Board and expert panel discussion: difficult to treat cases Case 1, Case 2, Case 3
12:20–12:30 Closing remarks
12:15–13:00 VISIT TO THE EXHIBITION & POSTER VIEWING
BETA HALL
Wednesday, April 22
Wed
nesd
ay, A
prill
22
Dermatoscopy course Scope satellite symposium at the EADO Keynote lecturesOpening ceremony Industry satellite symposium
Closing ceremony & awards Industry satellite lunch symposiumSymposium Social meeting
SCIENTIFIC POGRAMME16th EADO CONGRESS
8 F I N A L P R O G R A M M E
22-25 APRIL, 2020, RADISSON BLU HOTEL LIETUVA, VILNIUS, LITHUANIA
Wednesday, April 22
Dermatoscopy course Scope satellite symposium at the EADO Keynote lecturesOpening ceremony Industry satellite symposium
Closing ceremony & awards Industry satellite lunch symposiumSymposium Social meeting
15:30–17:00 SYMPOSIUM 2BIOLOGY OF SKIN CANCERCHAIRS: Amaya Virós (Manchester, UK)
15:45–15:57 New perspectives for the pathogenesis of cutaneous melanoma Amaya Virós (Manchester, UK)
16:00–16:12 MCC where does it come from Sara Valpione (Manchester, UK)
16:15–16:27 Biology of Dermatofibrosarcoma protuberans Celeste Lebbé (Paris, France)
16:30–16:42 New aspects of cutaneous lymphomasReinhard Dummer (Zurich, Switzerland)
16:45–16:57 The molecular signature of fast-growing melanomas Caroline Gaudy-Marqueste (Marseille, France)
17:00–17:30 COFFEE BREAK, VISIT TO THE EXHIBITION & POSTER VIEWING
17:30–18:45 SYMPOSIUM 4 BARRIERS TO ACCESS TO INNOVATIVE MEDICINES AND SUCCESSFUL ACCESS SCHEMES IN EUROPE: MULTI-STAKEHOLDER PANEL DISCUSSIONCHAIRS: Lidija Kandolf-Sekulovic (Belgrade, Serbia)
Ana-Maria Forsea (Bucharest, Romania)
17:30–17:45 “Innovative medicines: the challenge of combining swift patient access and health system sustainability.” Vision of the Task Force Access to Medicines of ECL Ward Rommel (Brussels, Belgium)
08:30–08:45 Confocal microscopy for melanoma diagnosis: evidence from Cochrane analysis to randomized trial Giovanni Pellacani (Modena, Italy
08:48–09:03 Confocal microscopy for other skin cancers: in vivo and ex vivo applications Javiera Perez (Barcelona, Spain)
09:06–09:21 OCT for non-melanoma skin cancer Julia Welzel (Augsburg, Germany)
09:24–09:39 Linear-scanning OCT Mariano Suppa, (Belgium, Brussels)
09:42–09:56 Other non-imaging tools and Artificial Intelligence Josep Malvehy (Barcelona, Spain)
10:00–10:30 COFFEE BREAK, VISIT TO THE EXHIBITION & POSTER VIEWING
10:30–12:00 SYMPOSIUM 7MEDICAL TREATMENT OF MELANOMACHAIRS: Dirk Schadendorf (Essen, Germany)
Michael Postow (New York, USA)
10:30–10:50 What do we know about sequencing and combining? Dirk Schadendorf (Essen, Germany)
10:53–11:13 Are neoadjuvant trials for translational research or a registrational pathway for new treatments? Alexander van Akkooi (Amsterdam, The Netherlands)
11:16–11:36 Where are we 5-years later with combined CTLA-4 + PD1 checkpoint blockade? Celeste Lebbe (Paris, France)
11:39–11:59 Where are we 5-years later with BRAF directed targeted therapy? Helen Gogas (Athens, Greece)
14:50–15:08 Evaluation of treatment outcome in actinic keratosis. What does it mean for efficacy? Rolf-Markus Szeimies (Recklinghausen, Germany)
15:10–15:28 News from the field–recent research on actinic keratosis Thomas Dirschka (Wuppertal, Germany)
15:30–16:00 COFFEE BREAK VISIT TO THE EXHIBITION & POSTER VIEWING
BETA HALL
BETA HALL
Dermatoscopy course Scope satellite symposium at the EADO Keynote lecturesOpening ceremony Industry satellite symposium
Closing ceremony & awards Industry satellite lunch symposiumSymposium Social meeting
Thursday, April 23
Thur
sday
, Apr
il 23
13w w w . e a d o 2 0 2 0 . c o m
22-25 APRIL, 2020, RADISSON BLU HOTEL LIETUVA, VILNIUS, LITHUANIA
16:00–17:00 SYMPOSIUM 10SKIN CANCER PREVENTION & SCREENINGCHAIRS: Veronique del Marmol (Brussels, Belgium)
Matilda Bylaitė-Bučinskienė (Vilnius, Lithuania)Dagmar Whitaker (Cape Town, South Africa)
16:00–16:12 Skin cancer awareness and early detection issues in the Baltic regionMatilda Bylaitė-Bučinskienė (Vilnius, Lithuania)
16:15–16:27 Sunscreen: the debateVeronique del Marmol (Brussels, Belgium)
16:30–16:42 Early detection for the biggest killers Ana-Maria Forsea (Bucharest, Romania)
16:45–16:57 Skin cancer prevention and screening–what works and what doesn’t workDagmar Whitaker (Cape Town, South Africa)
17:00–18:30 SYMPOSIUM 12THE NEW EUROPEAN BCC GUIDELINESCHAIRS: Ketty Peris (Rome, Italy)
Maria Concetta Fargnoli (L’Aquila, Italy)
17:00–17:12 How to define common and difficult-to-treat BCCKetty Peris (Rome, Italy)
17:15–17:27 Which are the indications for surgical excision?Roland Kaufmann (Frankfurt, Germany)
17:30–17:42 When should we consider topical or destructive treatments?Maria Concetta Fargnoli (L’Aquila, Italy)
17:45–17:57 Which BCCs require medical therapy?Axel Hauschild (Kiel, Germany)
18:00–18:12 Which follow-up schedule for which patients? Physicians recommendations and patient’s information.Veronique Bataille (London, UK)
18:15–18:27 How do we manage BCC lesions in NBCCS patients?Iris Zalaudek (Trieste, Italy)
BETA HALL
BETA HALL
Dermatoscopy course Scope satellite symposium at the EADO Keynote lecturesOpening ceremony Industry satellite symposium
Closing ceremony & awards Industry satellite lunch symposiumSymposium Social meeting
Thursday, April 23
Thur
sday
, Apr
il 23
SCIENTIFIC POGRAMME16th EADO CONGRESS
14 F I N A L P R O G R A M M E
22-25 APRIL, 2020, RADISSON BLU HOTEL LIETUVA, VILNIUS, LITHUANIA
Thursday, April 2310:30–12:00 FREE COMMUNICATIONS 1
GENETICS, BIOLOGY, DIAGNOSIS AND STAGING OF MELANOMACHAIRS: Veronique Bataille (London, UK)
Antonio Costanzo (Milan, Italy)
10:30–10:40 FC01 Defining the prognostic role of microRNAs in cutaneous melanoma Emi Dika (Bologna, Italy)
10:43–10:53 FC02 MX2 is involved in regulation of cell cycle in melanoma cells Marina Juraleviciute (Oslo, Norway)
10:56–11:06 FC03 AMBLor: a prognostic and companion biomarker for improved stratification of adjuvant therapy for AJCC stage II melanomaRob Ellis (Newcastle, UK)
11:09–11:19 FC04 Prognostic Risk Models Following AJCC Stage 1 Melanoma: A Systematic ReviewPatience Kunonga (Newcastle, UK)
11:22–11:32 FC05 Optimal Surveillance Strategies for AJCC Stage I Melanoma: The Health Technology Assessment (HTA) ApproachDiarmuid Coughlan (Newcastle, UK)
11:35–11:45 FC06 Validation of a clinicopathological and gene expression profile (CP-GEP) model to identify stage I and II melanoma patients at high risk for disease relapse E.E.A.P. Mulder (Amsterdam, The Netherlands)
11:48–11:58 FC07 Diagnostic accuracy of high-resolution ultrasound and fine needle aspiration for recurrence and locoregional metastases at follow-up in patients treated initially for stage I or stage II melanoma: a systematic review Margaret Astin (Newcastle, UK)
14:30–15:30 WORKSHOP 1SPITZOID TUMORSCHAIRS: Laura Held (Friedrichshafen, Germany)
Aimilios Lallas (Thessaloniki, Greece)
14:30–14:50 Histopathology, immunohistochemistry and molecular alterations in Spitzoid lesionsLaura Held (Friedrichshafen, Germany)
14:55–15:15 Clinical and dermatoscopic morphology of spitzoid tumors and management recommendationsAimilios Lallas (Thessaloniki, Greece)
15:20–15:30 Discussion
15:30–16:00 COFFEE BREAK, VISIT TO THE EXHIBITION & POSTER VIEWING
ZETA HALL
ZETA HALL
Dermatoscopy course Scope satellite symposium at the EADO Keynote lecturesOpening ceremony Industry satellite symposium
Closing ceremony & awards Industry satellite lunch symposiumSymposium Social meeting
Thur
sday
, Apr
il 23
15w w w . e a d o 2 0 2 0 . c o m
22-25 APRIL, 2020, RADISSON BLU HOTEL LIETUVA, VILNIUS, LITHUANIA
Thursday, April 2317:00–18:30 FREE COMMUNICATIONS 2
NON-MELANOMA SKIN CANCER CHAIRS: Alvydas Česas (Klaipėda, Lithuania)
Raimonds Karls (Riga, Latvia)
17:00–17:12 FC08 Surgery versus combined treatment with Curettage and Imiquimod for Nodular basal cell carcinoma (SCIN): 1-year results of a non-inferiority, randomized controlled trial Kelly Sinx (Maastricht, The Netherlands)
17:15–17:27 FC09 Daily practice data on 8 years’ experience with vismodegib in the Netherlands Klara Mosterd (Maastricht, The Netherlands)
17:30–17:42 FC10 Improved sun protection after melanoma diagnosis improves survival Ichiro Okamoto (Vienna, Austria)
17:45–17:57 FC11 HeberFERON as a therapeutic option for the treatment of advanced, high risk and multiple basal cell carcinomas Iraldo Bello Rivero (Havana, Cuba)
18:00–18:12 FC12 Neoadjuvant Vismodegib and Mohs Micrographic Surgery for Locally Advanced Periocular Basal Cell Carcinoma Gonzalez Abel (Buenos Aires, Argentina)
18:15–18:27 FC13 Intralesional oncolytic virotherapy results in tumor regression in cutaneous B-cell lymphoma Egle Ramelyte (Zurich, Switzerland)
ZETA HALL
Dermatoscopy course Scope satellite symposium at the EADO Keynote lecturesOpening ceremony Industry satellite symposium
Closing ceremony & awards Industry satellite lunch symposiumSymposium Social meeting
Thur
sday
, Apr
il 23
SCIENTIFIC POGRAMME16th EADO CONGRESS
16 F I N A L P R O G R A M M E
22-25 APRIL, 2020, RADISSON BLU HOTEL LIETUVA, VILNIUS, LITHUANIA
Friday, April 24ALFA HALL BETA HALL ZETA HALL
08:30–10:00 SYMPOSIUM 13Advanced SCC
SYMPOSIUM 14Who should receive adjuvant therapy in melanoma
10:00–10:30 COFFEE BREAK, VISIT TO THE EXHIBITION & POSTER VIEWING
10:30–12:00 SYMPOSIUM 15Difficult to treat subtypes of melanoma
SYMPOSIUM 16The new European SCC guidelines
FREE COMMUNICATIONS 3
12:15–13:15 INDUSTRY SATELLITE LUNCH SYMPOSIUM 2
13:15–14:15 KEYNOTE LECTURES 3What is new in melanoma?What is new in keratinocyte skin cancer?
14:30–15:30 INDUSTRY SATELLITE SYMPOSIUM 4
SYMPOSIUM 17Local therapies in melanoma
WORKSHOP 2Photodynamic therapy
15:30–16:00 COFFEE BREAK, VISIT TO THE EXHIBITION & POSTER VIEWING
16:00–17:00 SYMPOSIUM 18Cutaneous lymphoma
17:00–18:30 SYMPOSIUM 19Melanoma metastasis
SYMPOSIUM 20Management of cutaneous toxicities
FREE COMMUNICATIONS 4
Frid
ay, A
pril
24
17w w w . e a d o 2 0 2 0 . c o m
22-25 APRIL, 2020, RADISSON BLU HOTEL LIETUVA, VILNIUS, LITHUANIA
Friday, April 24
Dermatoscopy course Scope satellite symposium at the EADO Keynote lecturesOpening ceremony Industry satellite symposium
Closing ceremony & awards Industry satellite lunch symposiumSymposium Social meeting
08:30–10:00 SYMPOSIUM 13ADVANCED SCCCHAIRS: Axel Hauschild (Kiel, Germany)
Ulrike Leiter-Stöppke (Tuebingen, Germany)
08:30–08:45 Does surgery still play a role in advanced SCC? Roland Kaufmann (Frankfurt, Germany)
08:48–09:03 Impact of irradiation in the adjuvant and advanced setting Rita Steponavičienė (Vilnius, Lithuania)
09:06–09:21 Chemotherapie and EGFR antibodies for advanced SCC Eve Malbec (Bobigny, France)
10:30–10:40 FC14 Real-world outcomes on health-related quality of life in the non-interventional study NICO in Germany Peter Mohr (Buxtehude, Germany)
10:43–10:53 FC15 Prognosis and management of BRAF V600E-mutated pregnancy-associated melanoma Dimitrios C. Ziogas (Athens, Greece)
10:56–11:06 FC16 First-line immunotherapy with nivolumab plus ipilimumab versus targeted therapy with BRAF plus MEK inhibitors in patients with BRAF-mutant advanced melanoma: A real-world analysis Anna C. Pavlick (Princeton, USA)
11:09–11:19 FC17 Real-world efficacy of anti-PD-1 antibodies in advanced subungual melanoma: The large multicenter retrospective Japanese Acral Melanoma PD-1 (JAMP) study of 70 cases Yasuhiro Nakamura (Osaka, Japan)
11:22–11:32 FC18 2-year (yr) results and biomarker analysis of a phase 2, multicenter, randomized, open-label trial of efficacy and safety for talimogene laherparepvec (T-VEC) neoadjuvant (neo) treatment (tx) plus surgery (surg) vs surg in patients (pts) with resectable stage IIIB-IVM1a melanoma (MEL) Reinhard Dummer (Zurich, Switzerland)
11:35–11:45 FC19 A retrospective chart review study of realworld use of talimogene laherparepvec in unresectable stage IIIB-IVM1a melanoma in four European countries A.C.J. van Akkooi (Amsterdam, The Netherlands)
11:48–11:58 FC20 Final results of phase II trial (MIRACULUM) of the novel PD-1 inhibitor prolgolimab in patients with advanced melanoma Igor Samoylenko (Moscow, Russia)
BETA HALL
ZETA HALL
Dermatoscopy course Scope satellite symposium at the EADO Keynote lecturesOpening ceremony Industry satellite symposium
Closing ceremony & awards Industry satellite lunch symposiumSymposium Social meeting
Frid
ay, A
pril
24
21w w w . e a d o 2 0 2 0 . c o m
22-25 APRIL, 2020, RADISSON BLU HOTEL LIETUVA, VILNIUS, LITHUANIA
17:00–17:10 FC21 Bowen’s Disease in the Netherlands (1989-2017): Nationwide Incidence Rates and Risk of Cutaneous Squamous Cell Carcinoma Selin Tokez (Utrecht, The Netherlands)
17:13–17:23 FC22 The Real Burden of Cutaneous Squamous Cell Carcinoma in The Netherlands: Nationwide Incidence Rates of First and Multiple Tumors Selin Tokez (Utrecht, The Netherlands)
17:26–17:36 FC23 5 years recurrence rate of cutaneous squamous cell carcinoma of the head and neck Karolina Nemeth (Chesterfield, UK)
17:39–17:49 FC24 Squamous cell carcinoma of the lip. Ninety-nine invasive tumors treated with Mohs micrographic surgery. Local and regional recurrence. Prognostic factors Gonzalez Abel (Buenos Aires, Argentina)
17:52–18:02 FC25 A Multidisciplinary Consensus on the Treatment of Patients with Advanced Cutaneous Squamous Cell Carcinoma Scott M. Dinehart (Miami, USA)
18:05–18:15 FC26 Efficacy and Safety of Pembrolizumab for Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma (cSCC): Phase 2 KEYNOTE-629 Study Jean-Jacques Grob (Paris, France)
18:18–18:28 FC27 Efficacy and safety of immune checkpoint inhibitor cemiplimab in patients with locally advanced or metastatic squamocellular carcinoma Giulia Spallone (Rome, Italy)
ZETA HALL
ZETA HALL
Friday, April 24
Dermatoscopy course Scope satellite symposium at the EADO Keynote lecturesOpening ceremony Industry satellite symposium
Closing ceremony & awards Industry satellite lunch symposiumSymposium Social meeting
Frid
ay, A
pril
24
SCIENTIFIC POGRAMME16th EADO CONGRESS
22 F I N A L P R O G R A M M E
22-25 APRIL, 2020, RADISSON BLU HOTEL LIETUVA, VILNIUS, LITHUANIA